Tuberculosis (TB) is the leading cause of death worldwide among people infected with HIV. But as yet, no test can reliably show when latent (inactive) TB infections in people with HIV starts progressing to active--and potentially fatal--TB disease. Now, a researcher at Albert Einstein College of Medicine has received a five-year, $3.7 millionNational Institutes of Health grant to identify biomarkers that signal an increase in activity byMycobacterium tuberculosis (Mtb), the bacterium that causes TB, in people with HIV.
OSAP Disclaimer | Please notify our webmaster of any problems with this website. OSAP thanks its Super Sponsors for their support in 2017. Sponsorship does not imply endorsement by OSAP of a company's products or services.